版本:
中国

BRIEF-Respira Therapeutics says entered into strategic collaboration with United Therapeutics

April 12 Respira Therapeutics

* Respira Therapeutics says entered into a strategic collaboration with united therapeutics corporation for development and exclusive license of respira's rt234

* In addition, United Therapeutics will be lead investor in respira's series B preferred stock financing

* As per collaboration, United Therapeutics will provide co with non-dilutive development funding to advance rt234 through fda approval

* Additional terms of strategic collaboration were not disclosed

* To continue advancing development of other pipeline programs,to retain full control of research and development programs outside of pulmonary hypertension Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐